These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 35388153)

  • 1. What triggers severe COVID? Infected immune cells hold clues.
    Mallapaty S
    Nature; 2022 Apr; 604(7905):231. PubMed ID: 35388153
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy.
    Jiang Y; Rubin L; Peng T; Liu L; Xing X; Lazarovici P; Zheng W
    Int J Biol Sci; 2022; 18(2):459-472. PubMed ID: 35002503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of the inflammatory response and megakaryocytes in COVID-19 infection.
    Battina HL; Alentado VJ; Srour EF; Moliterno AR; Kacena MA
    Exp Hematol; 2021 Dec; 104():32-39. PubMed ID: 34563606
    [No Abstract]   [Full Text] [Related]  

  • 4. Can Natural Killer Cells Be a Principal Player in Anti-SARS-CoV-2 Immunity?
    Ahmed F; Jo DH; Lee SH
    Front Immunol; 2020; 11():586765. PubMed ID: 33365027
    [No Abstract]   [Full Text] [Related]  

  • 5. The 49th Annual Meeting of the Japanese Society for Immunology: COVID-19 and Immunity.
    Shinkura R; Kang S; Arase H; Toyama-Sorimachi N
    Int Immunol; 2021 Mar; 33(4):193-196. PubMed ID: 33538811
    [No Abstract]   [Full Text] [Related]  

  • 6. Rogue antibodies could be driving severe COVID-19.
    Khamsi R
    Nature; 2021 Feb; 590(7844):29-31. PubMed ID: 33469204
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune Responses to the Novel Coronavirus-2: Friend or Foe?
    Mahmoodpoor A; Nader ND
    Immunol Invest; 2021 Nov; 50(8):949-951. PubMed ID: 32689852
    [No Abstract]   [Full Text] [Related]  

  • 8. [Involvement of the complement cascade in severe forms of COVID-19].
    Chouaki Benmansour N; Carvelli J; Vivier É
    Med Sci (Paris); 2021 Apr; 37(4):333-341. PubMed ID: 33835019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The journey of SARS-CoV-2 in human hosts: a review of immune responses, immunosuppression, and their consequences.
    Alshammary AF; Al-Sulaiman AM
    Virulence; 2021 Dec; 12(1):1771-1794. PubMed ID: 34251989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.
    Chen R; Lan Z; Ye J; Pang L; Liu Y; Wu W; Qin X; Guo Y; Zhang P
    Front Immunol; 2021; 12():589095. PubMed ID: 33995341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 and diabetes: the contributions of hyperglycemia.
    Wang J; Meng W
    J Mol Cell Biol; 2020 Sep; 12(12):958-962. PubMed ID: 33002109
    [No Abstract]   [Full Text] [Related]  

  • 12. The emergence of a new cytokine storm during the COVID-19 pandemic: Multisystem inflammatory syndrome in children.
    Yang MC; Tsai CC; Su YT; Wu JR
    Kaohsiung J Med Sci; 2021 Mar; 37(3):255-256. PubMed ID: 33400372
    [No Abstract]   [Full Text] [Related]  

  • 13. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19.
    Bonaventura A; Vecchié A; Dagna L; Martinod K; Dixon DL; Van Tassell BW; Dentali F; Montecucco F; Massberg S; Levi M; Abbate A
    Nat Rev Immunol; 2021 May; 21(5):319-329. PubMed ID: 33824483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cytokine storm-An appropriate, over-reactive response to SARS-CoV-2 or the wrong immune pathway?
    Bellgrau D; Modiano JF
    Scand J Immunol; 2021 Mar; 93(3):e12979. PubMed ID: 32991014
    [No Abstract]   [Full Text] [Related]  

  • 15. [The neurology of COVID-19].
    Cuevas-García C; Calderón-Vallejo A; Berrón-Ruiz L
    Rev Alerg Mex; 2020; 67(4):338-349. PubMed ID: 33631902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Des-Arg9 bradykinin and bradykinin potentially trigger cytokine storm in patients with COVID-19.
    Alikhani M; Javadi A; Aalikhani M
    Iran J Immunol; 2021 Mar; 18(1):93-94. PubMed ID: 33787518
    [No Abstract]   [Full Text] [Related]  

  • 17. Complex immune deregulation in severe COVID-19: More than a mechanism of pathogenesis.
    Giamarellos-Bourboulis EJ
    EBioMedicine; 2021 Nov; 73():103673. PubMed ID: 34742130
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor Necrosis Factor-Alpha Exacerbates Viral Entry in SARS-CoV2-Infected iPSC-Derived Cardiomyocytes.
    Lee CY; Huang CH; Rastegari E; Rengganaten V; Liu PC; Tsai PH; Chin YF; Wu JR; Chiou SH; Teng YC; Lee CW; Liang Y; Chen AY; Hsu SC; Hung YJ; Sun JR; Chien CS; Chien Y
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 and Kounis Syndrome: Deciphering Their Relationship.
    Kounis NG; Koniari I; de Gregorio C
    Balkan Med J; 2021 May; 38(3):145-149. PubMed ID: 34142957
    [No Abstract]   [Full Text] [Related]  

  • 20. Can BCG vaccine protect against COVID-19 via trained immunity and tolerogenesis?
    Basak P; Sachdeva N; Dayal D
    Bioessays; 2021 Mar; 43(3):e2000200. PubMed ID: 33169410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.